This excerpt taken from the CRXL 6-K filed Aug 12, 2009.
The Group adopted IFRS 8 Operating Segments, which replaces IAS 14, Segment reporting, as of January 1, 2007. The Group identified the Management Board as the chief operating decision maker. The Management Board reviews the consolidated operating results regularly to make decisions about resources and to assess overall performance. This led to the identification of one reportable segment, which comprises the development, production and marketing of products that combat infectious diseases.
This excerpt taken from the CRXL 20-F filed May 7, 2008.
Segment the products, focusing on those with higher margins. As noted above, we are already segmenting our products on a geographical basis. However, we also segment our products by creating variations of a vaccine that target a particular market, as we did with Epaxal® by introducing Epaxal® Junior aimed at the paediatric market.